PRESS RELEASE published on 03/30/2026 at 08:30, 4 months 2 days ago NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer NANOBIOTIX announces first data from phase 2 trial on JNJ-1900 for stage 3 lung cancer presented by Johnson & Johnson at European Lung Cancer Conference Phase 2 Trial NANOBIOTIX Lung Cancer Johnson & Johnson JNJ-1900
BRIEF published on 03/26/2026 at 21:20, 4 months 6 days ago Nanobiotix Announces the Publication of its 2025 Annual Results Financial Results Biotechnology NANOBIOTIX Online Conference Nanoparticles
BRIEF published on 03/26/2026 at 21:20, 4 months 6 days ago NANOBIOTIX to Release 2025 Financial Results and Update Conference Call Biotechnology Market Update 2025 Financial Results Nanoparticle Treatments
PRESS RELEASE published on 03/26/2026 at 21:15, 4 months 6 days ago NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 Nanobiotix to announce fourth quarter and full year 2025 operational and financial update on March 31, 2026. Conference call and webcast scheduled for April 1, 2026 Conference Call Webcast Financial Update NANOBIOTIX Late-clinical Stage Biotechnology
BRIEF published on 03/25/2026 at 15:16, 4 months 7 days ago NANOBIOTIX denies takeover rumors Biotechnology Takeover NANOBIOTIX Rumors Nanoparticles
BRIEF published on 03/25/2026 at 15:16, 4 months 7 days ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
PRESS RELEASE published on 03/25/2026 at 15:11, 4 months 7 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 4 months 20 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 4 months 20 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 5 months 4 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
Published on 08/01/2026 at 01:20, 1 day 6 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 6 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 7 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 8 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/01/2026 at 16:35, 15 hours 34 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 12 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 13 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:53, 1 day 13 hours ago Deutsche EuroShop SE: Conversion into a European Company Successfully Completed
Published on 07/31/2026 at 21:00, 1 day 11 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 12 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 13 hours ago Covivio Hotels - 2026 Half-year financial report
